Effects of variables on hospital mortality in univariate and multivariate logistic regression analysis in all patients with ACS
| Variables | Unadjusted OR (95% CI) | P value | Adjusted OR (95% CI) | P value |
| Age | 1.05 (1.04 to 1.06) | <0.001 | 1.04 (1.03 to 1.05) | <0.001 |
| Male | 0.56 (0.46 to 0.75) | <0.001 | 0.625 | |
| AMI (UA as ref) | 8.40 (5.30 to 13.30) | <0.001 | 5.71 (3.50 to 9.31) | <0.001 |
| Hypertension | 0.59 (0.47 to 0.76) | <0.001 | – | 0.897 |
| Heart failure | 2.05 (1.61 to 2.61) | <0.001 | – | 0.774 |
| Hyperlipidaemia | 0.58 (0.43 to 0.79) | <0.001 | – | 0.075 |
| Atrial fibrillation | 1.78 (1.38 to 2.28) | <0.001 | 1.47 (1.08 to 2.00) | 0.015 |
| Aspirin | 0.47 (0.37 to 0.61) | <0.001 | – | 0.504 |
| ACEI | 0.25 (0.18 to 0.34) | <0.001 | 0.40 (0.27 to 0.60) | <0.001 |
| β blocker | 0.19 (0.14 to 0.24) | <0.001 | 0.49 (0.34 to 0.71) | <0.001 |
| Clopidogrel | 0.66 (0.48 to 0.92) | 0.014 | – | 0.618 |
| Diuretic | 0.59 (0.46 to 0.75) | <0.001 | – | 0.145 |
| Statin | 0.26 (0.20 to 0.36) | <0.001 | 0.57 (0.39 to 0.83) | 0.004 |
| Insulin | 0.56 (0.43 to 0.72) | <0.001 | 0.961 | |
| Oral hypoglycaemic agents | 0.09 (0.02 to 0.37) | 0.001 | 0.23 (0.05 to 0.95) | 0.042 |
| WCC | 1.09 (1.07 to 1.12) | <0.001 | 1.06 (1.03 to 1.08) | <0.001 |
| Haemoglobin | 0.91 (0.86 to 0.96) | 0.001 | – | 0.160 |
| Creatinine | 1.37 (1.26 to 1.48) | <0.001 | – | 0.159 |
| SOFA score | 1.36 (1.31 to 1.41) | <0.001 | 1.25 (1.19 to 1.30) | <0.001 |
| Glucosemax (<6.1) | Ref. | <0.001 | Ref. | <0.001 |
| Glucosemax (6.1–11.1) | 1.76 (0.71 to 4.41) | 0.23 | 2.42 (0.86 to 6.80) | 0.095 |
| Glucosemax (11.1–16.6) | 5.12 (2.06 to 12.73) | <0.001 | 4.33 (1.55 to 12.13) | 0.005 |
| Glucosemax (≥16.6) | 13.41 (5.35 to 33.61) | <0.001 | 7.27 (2.56 to 20.62) | <0.001 |
ACEI, ACE inhibitor; ACS, acute coronary syndrome; AMI, acute myocardial infarction; SOFA, sequential organ failure assessment; UA, unstable angina; WCC, white cell count.